[HTML][HTML] The cost-effectiveness of transplanting hearts from hepatitis C-infected donors into uninfected recipients

AE Woolley, AR Gandhi, ML Jones, JJ Kim… - …, 2023 - journals.lww.com
Background. The DONATE HCV trial demonstrated the safety and efficacy of transplanting
hearts from hepatitis C viremic (HCV+) donors. In this report, we examine the cost …